Navigation Links
Walgreens Set to Present at CBI's 3rd Forum on Strategic Distribution Planning for Specialty Products

WOBURN, Mass., Aug. 23, 2012 /PRNewswire/ -- CBI's 3rd Annual Forum on Strategic Distribution for Specialty Products boasts a speaking faculty that includes Todd Grisco, Vice President, Retail Strategy; Anita Dopkosky, Specialty Account Director at Walgreens; and Keith Loehlein, Senior Principal, Supplier Services, IMS.

This September 20–21, attendees will come together with these experts during the in-conference workshop, Optimize a Multi-Channel Approach, for a deep dive into the intricacies of a multi-channel strategy by exploring which products are best suited to take this direction along with outcomes to date. Attendees will also delve into payer considerations including reimbursement tendencies, options and trends being seen in alternate sites of care.

This workshop at CBI's 3rd Annual Strategic Distribution Planning for Specialty Products kicks off a strong agenda filled with practical experiences and strategies offering top executives involved in channel strategy a roadmap for ensuring pull-through, use and reimbursement of products within this competitive market segment.

The program is being led by Conference Chairman Mike Castagna, Executive Director, Immunoscience Division at Bristol-Myers Squibb. The Industry Keynote Address is being provided by Michael Howe, Senior Director, Trade Relations, at UCB Inc.

About CBI

CBI, an Advanstar company, is the leading provider of market-driven, unbiased conferences for the pharmaceutical, biotechnology, medical device and healthcare industries. CBI offers specialized information presented in interactive formats by thought leaders and regulators.

Kristina Weljkovic
Phone number: 339-298-2285
Email address:

This press release was issued through eReleases® Press Release Distribution. For more information, visit

SOURCE The Center for Business Intelligence
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. MAP Pharmaceuticals to Present at Upcoming Investor Conferences
2. Auxilium Pharmaceuticals, Inc. to Present at the Canaccord Genuity 32nd Annual Growth Conference
3. MiMedx Group to Present at the Canaccord Genuity Annual Growth Conference
4. Robert Kirsner, MD, PhD, To Present Results For Phase 2b 6-Month Follow-Up Trial Of Unique Investigational Cell-Based Therapy For Venous Leg Ulcers
5. Keryx Biopharmaceuticals to Present at The 7th Annual JMP Securities Healthcare Conference
6. PROLOR Biotech Announces Presentation of Data on Its Long-Acting Clotting Factors at World Federation of Hemophilia World Congress
7. InterMune To Present At JMP Securities Healthcare Conference
8. Auxilium Pharmaceuticals, Inc. to Present At The JMP Securities 2012 Healthcare Conference
9. InspireMD to Present at JMP Securities Healthcare Conference on July 12th in New York
10. InspireMD to Present at JMP Securities Healthcare Conferenceon July 12th in New York
11. Sangamo BioSciences Announces Presentation at Seventh Annual JMP Securities Healthcare Conference
Post Your Comments:
(Date:6/23/2016)... , June 23, 2016 Apellis ... Phase 1 clinical trials of its complement C3 ... single and multiple ascending dose studies designed to ... (PD) of subcutaneous injection in healthy adult volunteers. ... (SC) either as a single dose (ranging from ...
(Date:6/23/2016)... -- On Wednesday, June 22, 2016, the NASDAQ ... Dow Jones Industrial Average edged 0.27% lower to finish at ... has initiated coverage on the following equities: Infinity Pharmaceuticals ... NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ ... Learn more about these stocks by accessing their free trade ...
(Date:6/23/2016)... ... June 23, 2016 , ... Velocity Products, a division of ... and optimized exclusively for Okuma CNC machining centers at The International Manufacturing Technology ... among several companies with expertise in toolholding, cutting tools, machining dynamics and distribution, ...
(Date:6/22/2016)... SAN DIEGO , June 22, 2016 /PRNewswire/ ... partnership that will allow them to produce up ... (HiPSC) from one lot within one week. These ... their time laboriously preparing cells and spend more ... made possible through a proprietary, high-volume manufacturing process ...
Breaking Biology Technology:
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted to ... of 2015 The gross margin was 49% (27) ... operating margin was 40% (-13) Earnings per share rose ... was SEK 249.9 M (21.2) , Outlook   ... The operating margin for 2016 is estimated to exceed ...
(Date:4/15/2016)... CHICAGO , April 15, 2016  A ... companies make more accurate underwriting decisions in a ... offering timely, competitively priced and high-value life insurance ... health screenings. With Force Diagnostics, rapid ... and lifestyle data readings (blood pressure, weight, pulse, ...
(Date:3/31/2016)... , March 31, 2016 ... ) ("LegacyXChange" or the "Company") LegacyXChange is ... users of its soon to be launched online site ... ) will also provide potential shareholders ... of DNA technology to an industry that is notorious ...
Breaking Biology News(10 mins):